Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial

Elizabeth T Jacobs, Anna R. Giuliano, Denise Roe, José M. Guillén-Rodríguez, Lisa M. Hess, David S Alberts, María Elena Martínez

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The Wheat Bran Fiber (WBF) trial was a double-blind Phase III clinical trial in which participants were randomized to a cereal fiber supplement of either 13.5 or 2.0 g/day. No protective effect for adenoma recurrence was observed for those randomized to the high-fiber group as compared with those in the low-fiber group. However, the high-fiber group had significantly lower adherence to the supplement as assessed by cereal box counts. The aim of this study was to determine whether reported supplemental and total fiber intake affected colorectal adenoma recurrence in the WBF trial population, regardless of treatment group assignment. A total of 1208 participants who completed the WBF trial had a colonoscopy before the date of the last cereal box count and/or at least one colonoscopy within 90 days after it and, thus, were eligible for the current analyses. Statistical analyses were done using multivariate logistic regression models that included potentially confounding variables. Compared with individuals consuming less than 1.8 g/day of supplemental fiber, the adjusted odds ratio (95% confidence interval) for adenoma recurrence for those consuming greater than 11.0 g/day was 0.94 (0.66-1.33). The odds ratio (95 % confidence interval) for participants whose total fiber intake was greater than 30.3 g/day was 0.98 (0.68-1.42) compared with those whose intake was less than 17.9 g/day. The results of this study show that neither fiber intake from a wheat bran supplement nor total fiber intake affects the recurrence of colorectal adenomas, thus lending further evidence to the body of literature indicating that consumption of a high-fiber diet, especially one rich in cereal fiber, does not reduce the risk of colorectal adenoma recurrence.

Original languageEnglish (US)
Pages (from-to)906-914
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume11
Issue number9
StatePublished - Sep 2002

Fingerprint

Dietary Fiber
Adenoma
Recurrence
Colonoscopy
Logistic Models
Odds Ratio
Confidence Intervals
Phase III Clinical Trials
Confounding Factors (Epidemiology)
Diet
Edible Grain
Population

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial. / Jacobs, Elizabeth T; Giuliano, Anna R.; Roe, Denise; Guillén-Rodríguez, José M.; Hess, Lisa M.; Alberts, David S; Martínez, María Elena.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 11, No. 9, 09.2002, p. 906-914.

Research output: Contribution to journalArticle

Jacobs, Elizabeth T ; Giuliano, Anna R. ; Roe, Denise ; Guillén-Rodríguez, José M. ; Hess, Lisa M. ; Alberts, David S ; Martínez, María Elena. / Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial. In: Cancer Epidemiology Biomarkers and Prevention. 2002 ; Vol. 11, No. 9. pp. 906-914.
@article{dda525ac48c44470949bf3dc9894ac6b,
title = "Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial",
abstract = "The Wheat Bran Fiber (WBF) trial was a double-blind Phase III clinical trial in which participants were randomized to a cereal fiber supplement of either 13.5 or 2.0 g/day. No protective effect for adenoma recurrence was observed for those randomized to the high-fiber group as compared with those in the low-fiber group. However, the high-fiber group had significantly lower adherence to the supplement as assessed by cereal box counts. The aim of this study was to determine whether reported supplemental and total fiber intake affected colorectal adenoma recurrence in the WBF trial population, regardless of treatment group assignment. A total of 1208 participants who completed the WBF trial had a colonoscopy before the date of the last cereal box count and/or at least one colonoscopy within 90 days after it and, thus, were eligible for the current analyses. Statistical analyses were done using multivariate logistic regression models that included potentially confounding variables. Compared with individuals consuming less than 1.8 g/day of supplemental fiber, the adjusted odds ratio (95{\%} confidence interval) for adenoma recurrence for those consuming greater than 11.0 g/day was 0.94 (0.66-1.33). The odds ratio (95 {\%} confidence interval) for participants whose total fiber intake was greater than 30.3 g/day was 0.98 (0.68-1.42) compared with those whose intake was less than 17.9 g/day. The results of this study show that neither fiber intake from a wheat bran supplement nor total fiber intake affects the recurrence of colorectal adenomas, thus lending further evidence to the body of literature indicating that consumption of a high-fiber diet, especially one rich in cereal fiber, does not reduce the risk of colorectal adenoma recurrence.",
author = "Jacobs, {Elizabeth T} and Giuliano, {Anna R.} and Denise Roe and Guill{\'e}n-Rodr{\'i}guez, {Jos{\'e} M.} and Hess, {Lisa M.} and Alberts, {David S} and Mart{\'i}nez, {Mar{\'i}a Elena}",
year = "2002",
month = "9",
language = "English (US)",
volume = "11",
pages = "906--914",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial

AU - Jacobs, Elizabeth T

AU - Giuliano, Anna R.

AU - Roe, Denise

AU - Guillén-Rodríguez, José M.

AU - Hess, Lisa M.

AU - Alberts, David S

AU - Martínez, María Elena

PY - 2002/9

Y1 - 2002/9

N2 - The Wheat Bran Fiber (WBF) trial was a double-blind Phase III clinical trial in which participants were randomized to a cereal fiber supplement of either 13.5 or 2.0 g/day. No protective effect for adenoma recurrence was observed for those randomized to the high-fiber group as compared with those in the low-fiber group. However, the high-fiber group had significantly lower adherence to the supplement as assessed by cereal box counts. The aim of this study was to determine whether reported supplemental and total fiber intake affected colorectal adenoma recurrence in the WBF trial population, regardless of treatment group assignment. A total of 1208 participants who completed the WBF trial had a colonoscopy before the date of the last cereal box count and/or at least one colonoscopy within 90 days after it and, thus, were eligible for the current analyses. Statistical analyses were done using multivariate logistic regression models that included potentially confounding variables. Compared with individuals consuming less than 1.8 g/day of supplemental fiber, the adjusted odds ratio (95% confidence interval) for adenoma recurrence for those consuming greater than 11.0 g/day was 0.94 (0.66-1.33). The odds ratio (95 % confidence interval) for participants whose total fiber intake was greater than 30.3 g/day was 0.98 (0.68-1.42) compared with those whose intake was less than 17.9 g/day. The results of this study show that neither fiber intake from a wheat bran supplement nor total fiber intake affects the recurrence of colorectal adenomas, thus lending further evidence to the body of literature indicating that consumption of a high-fiber diet, especially one rich in cereal fiber, does not reduce the risk of colorectal adenoma recurrence.

AB - The Wheat Bran Fiber (WBF) trial was a double-blind Phase III clinical trial in which participants were randomized to a cereal fiber supplement of either 13.5 or 2.0 g/day. No protective effect for adenoma recurrence was observed for those randomized to the high-fiber group as compared with those in the low-fiber group. However, the high-fiber group had significantly lower adherence to the supplement as assessed by cereal box counts. The aim of this study was to determine whether reported supplemental and total fiber intake affected colorectal adenoma recurrence in the WBF trial population, regardless of treatment group assignment. A total of 1208 participants who completed the WBF trial had a colonoscopy before the date of the last cereal box count and/or at least one colonoscopy within 90 days after it and, thus, were eligible for the current analyses. Statistical analyses were done using multivariate logistic regression models that included potentially confounding variables. Compared with individuals consuming less than 1.8 g/day of supplemental fiber, the adjusted odds ratio (95% confidence interval) for adenoma recurrence for those consuming greater than 11.0 g/day was 0.94 (0.66-1.33). The odds ratio (95 % confidence interval) for participants whose total fiber intake was greater than 30.3 g/day was 0.98 (0.68-1.42) compared with those whose intake was less than 17.9 g/day. The results of this study show that neither fiber intake from a wheat bran supplement nor total fiber intake affects the recurrence of colorectal adenomas, thus lending further evidence to the body of literature indicating that consumption of a high-fiber diet, especially one rich in cereal fiber, does not reduce the risk of colorectal adenoma recurrence.

UR - http://www.scopus.com/inward/record.url?scp=0036716901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036716901&partnerID=8YFLogxK

M3 - Article

C2 - 12223437

AN - SCOPUS:0036716901

VL - 11

SP - 906

EP - 914

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -